Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T77786 |
TGFβ-IN-5
WAY-641966 |
TGF-beta/Smad | Stem Cells |
TGFβ-IN-5 (WAY-641966) 是一种有效的 TGFβ 抑制剂,具有抗朊病毒活性,可用于研究与 TGF-β 信号转导相关的纤维增殖性疾病。 | |||
T60596 | TGFβ-IN-1 | ||
TGFβ-IN-1一种通过抑制转化生长因子β信号通路的抗肿瘤生长和转移剂。 | |||
T61586 |
TGFβ-IN-2
|
||
TGFβ-IN-2 (Compound 9d) effectively inhibits the accumulation of total collagen induced by TGF-β in NRK-49F cells, with an IC 50 value of 4.31 μM. It also suppresses the in vitro protein expression of COL1A1, α-SMA, and p-Smad3, which are induced by TGF-β. Additionally, TGFβ-IN-2 shows promise as a potential anti-fibrosis compound for in vivo applications through oral administration [1]. | |||
T75004 |
TGFβ1-IN-2
|
Others | Others |
TGFβ1-IN-2,一种二芳基酰基腙衍生物,有效抑制成纤维细胞活化与增殖,常用于特发性肺纤维化(IPF)研究。 | |||
T75005 |
TGFβ1-IN-3
|
Others | Others |
TGFβ1-IN-3 是一种二芳基酰基腙衍生物,对成纤维细胞的活化和增殖有抑制作用。TGFβ1-IN-3 是治疗特发性肺纤维化 (IPF) 的候选化合物。 | |||
T61389 |
TGFβ1-IN-1
|
TGF-beta/Smad | Stem Cells |
TGFβ1-IN-1 是一种具有口服活性的 TGF-β1 抑制剂,抑制 TGF-β1 诱导的纤维化标志物(α-SMA 和纤连蛋白)的产生,可用于研究癌症和自身免疫疾病。 | |||
T9523 |
TGFβRI-IN-3
|
TGF-beta/Smad | Stem Cells |
TGFβRI-IN-3 抑制TGFβR1,IC50为 0.79 nM,是对 MAP4K4 的选择性2000 倍。TGFβRI-IN-3 是一种高选择性的 TGFβR1 抑制剂,在免疫肿瘤中具有潜在的应用。 | |||
T21714 |
BMS453
BMS 453,BMS-189453 |
Retinoid Receptor | Metabolism |
BMS453 (BMS-189453) 是一种合成类维生素 A,是一种 RARβ激动剂,也是一种 RARα/RARγ拮抗剂。它主要通过诱导活性 TGFβ 来抑制乳腺细胞生长。 | |||
T6496 |
Vactosertib
TEW-7197,EW-7197 |
ALK; TGF-beta/Smad | Angiogenesis; Stem Cells; Tyrosine Kinase/Adaptors |
Vactosertib (EW-7197) 是有效的、具有 ATP 竞争性的、具有口服活性的激活素受体样激酶 5 (ALK5) 抑制剂(IC50:12.9 nM)。它还以纳摩尔浓度抑制 ALK2 和 ALK4 (IC50为 17.3 nM),表现出强大的抗转移活性和抗癌作用。 | |||
T72976 |
TGFβRI-IN-6
|
||
TGFβRI-IN-6 是一种有效的TGFβRI 抑制剂,IC50值为 0.55 nM。TGFβRI-IN-6 具有增强抗肿瘤免疫力的潜力。 | |||
T74163 |
TGFβR-IN-1
|
||
TGFβR-IN-1 是一种长效肿瘤激活的TGFβR 抑制剂的前体。 | |||
T62559 | TGFβRI-IN-4 | ||
TGFβRI-IN-4 是一种高效的、口服具有活力的 TGFβ 受体 I 型激酶 (TGFβRI) 抑制剂,能够作用于 ALK5 (IC50: 44 nM) 和 NIH3T3 (IC50: 42.5 nM)。TGFβRI-IN-4 在异种移植瘤模型中,能够抑制肿瘤生长和肿瘤重量。 | |||
T60931 |
TGFβRI-IN-5
|
||
TGFβRI-IN-5 (Compound 4b) 是 TGFβRI 的有效抑制剂,IC50值为 0.08 μM。TGFβRI-IN-5 对所有测试细胞系的均显示出显著的抗癌活性,可增强细胞凋亡并抑制细胞周期的 G2/M 期。 | |||
T76066 |
pm26TGF-β1 peptide
|
||
pm26TGF-β1 peptide为模拟人TGF-β1分子的肽,对TGF-β1受体展现高亲和力。该肽显示出有效抗炎特性,无嗜中性粒细胞的趋化性。 | |||
T82951 |
a-TGF (34-43), rat
|
||
a-TGF (34-43), rat 是一种用于免疫研究的活性肽。 | |||
T76066L |
pm26TGF-β1 peptide TFA
|
||
pm26TGF-β1 peptide TFA 是模拟人类TGF-β1分子的肽,对TGF-β1受体有高亲和力。该化合物具备显著的抗炎性能,不引起嗜中性粒细胞的趋化现象。 | |||
T13137 | TGFβRI-IN-1 | TGF-beta/Smad | Stem Cells |
TGFβRI-IN-1 is an oral active and selective inhibitor of TGFβ receptor type I (TGFβRI) kinase(IC50 values of 2 nM and 7.6 μM for TGFβRI and TGFβRII, respectively ). | |||
T2273 |
ITD-1
4-[1,1'-联苯]-4-基-1,4,5,6,7,8-六氢-2,7,7-三甲基-5-氧代-3-喹啉羧酸乙酯 |
TGF-beta/Smad | Stem Cells |
ITD1 是一个选择性的TGFβ受体抑制剂(IC50:460 nM)。 | |||
T35896 |
AZ 12799734
AZ12799734 |
ALK | Angiogenesis; Tyrosine Kinase/Adaptors |
AZ 12799734 是一种具有口服活性、选择性和有效性的 TGFBR1和 ALK5 双重抑制剂,对 BMP 和 TGFβ 有抑制作用,可用于研究肿瘤。 | |||
T5197 |
BIBF0775
|
ALK; TGF-beta/Smad | Angiogenesis; Stem Cells; Tyrosine Kinase/Adaptors |
BIBF0775 是一种选择性的TGFβI 型受体抑制剂(IC50:34 nM)。 | |||
T61301 |
Chromenone 1
|
TGF-beta/Smad | Stem Cells |
Chromenone 1 是一种有效的成骨骨形态发生蛋白(BMP)增强剂,其通过诱导显著的非激酶依赖的负TGFβ反馈,独特地增强了核BMP-Smad信号输出。 | |||
T2247 |
KenPaullone
9-Bromopaullone,NSC-664704,9-溴-7,12-二氢吲哚并[3,2-D][1]苯并氮杂卓-6(5H)-酮 |
GSK-3; CDK | Cell Cycle/Checkpoint; PI3K/Akt/mTOR signaling; Stem Cells |
KenPaullone (9-Bromopaullone) 是一种CDK1/cyclin B 和GSK-3β抑制剂,IC50值分别为 0.4 μM 和 23 nM。它也抑制 CDK2/cyclin A、CDK2/cyclin E 和 CDK5/p25 的活性,IC50值分别为 0.68 μM、7.5 μM 和 0.85 μM。。它通过增强 TGFβ-Smad3 信号通路增加和延长 foxp3 基因的转录来促进 iTreg 细胞分化。 | |||
T8730 |
BMS986260
|
TGF-beta/Smad | Stem Cells |
BMS986260是一种口服有活力的选择性TGFβR1抑制剂,是免疫肿瘤学药物。它能够抑制 MINK 和 NHLF 细胞系中 TGFβ 介导的 pSMAD2/3 核转位,IC50值分别为 350 nM 和 190 nM。它对 TGFβR1 的选择比 TGFβR2 同功酶高。 | |||
T70334 |
SRI-31277
|
||
SRI-31277 is a TSP1-TGFβ inhibitor. | |||
T26280 |
TL4-12
TL4 12 |
||
TL4-12 is a MAP4K2 (GCK) inhibitor that inhibits IL-1 and TGFβ-induced p38 MAPK phosphorylation in vitro. | |||
TP2147 |
LSKL, Inhibitor of Thrombospondin (TSP-1) (TFA)
|
Others | Others |
LSKL, Inhibitor of Thrombospondin (TSP-1) TFA, a latency-associated protein (LAP)-TGFβ derived tetrapeptide, is a competitive antagonist of TGF-β1. | |||
T62615 |
ALK5-IN-30
|
||
ALK5-IN-30 (EX-07) 是一种 ALK 的有效抑制剂,其对 ALK5 (IC50< 10 nM) 和 TGFβ-R1 (IC50< 10 nM) 具有抑制作用。 | |||
T73016 |
THRX-144644
|
||
THRX-144644 是一种肺限制性 ALK5抑制剂,其 IC50值为 0.14 nM。THRX-144644 避免了与 TGFβ 途径抑制相关的全身毒性。 | |||
T41151 |
K34c
|
||
K34c is a potent and selective α5β1 integrin inhibitor (IC50 = 3.1 nM). K34c inhibits cell survival and migration, inhibits p53-dependent senescence induced by Temozolomide or Ellipticine and promotes apoptosis in U87MG cells. K34c also prevents TGFβ-induced infiltrationin vivoand reduces cell adhesion on fibronectin. | |||
T10444 |
TAK1/MAP4K2 inhibitor 1
|
Others | Others |
TAK1/MAP4K2 inhibitor 1 is a potent dual inhibitor of TGFβ-activated kinase 1 (TAK1) and MAP4K2 (IC50s: 41.1 nM and 18.2 nM). | |||
T76052 |
ELA-32(human) TFA
|
||
ELA-32(human) TFA is a potent, high affinityapelin receptoragonist (IC50=0.27 nM; Kd=0.51 nM). ELA-32(human) TFA exhibits no binding GPR15 and GPR25. ELA-32(human) TFA activates the PI3K/AKT pathway and promotes self-renewal of hESCs via cell-cycle progression and protein translation. ELA-32(human) TFA also potentiates the TGFβ pathway, priming hESCs toward the endoderm lineage. ELA-32(human) TFA stimulates angiogenesis in HUVEC cells. | |||
TP2097 |
ELA-32(human)
ELA-32 (human) |
||
Potent, high affinity apelin receptor agonist (IC50 = 0.27 nM; Kd = 0.51 nM). Exhibits no binding GPR15 and GPR25. Activates the PI3K/AKT pathway and promotes self-renewal of hESCs via cell-cycle progression and protein translation. Also potentiates the T | |||
T36779 |
NG 25 (hydrochloride hydrate)
|
||
NG 25 is a type II kinase inhibitor that inhibits MAP4K2 and TAK1 (IC50s = 21.7 and 149 nM, respectively).1It also inhibits the Src family kinases Src and LYN (IC50s = 113 and 12.9 nM, respectively) and Abl family kinases (IC50s = 75.2 nM), as well as CSK, FER, and p38α (IC50s = 56.4, 82.3, and 102 nM, respectively). NG 25 (100 nM) prevents TNF-α-induced IKKα/β phosphorylation and IκB-α degradation in L929 cells. It inhibits secretion of IFN-α and IFN-β induced by CpG type B and CL097, respectiv... |